Lucid Diagnostics Inc.
Lucid Diagnostics Inc. (LUCD): 1 pipeline candidate · 6 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E 7.52 · 0% dilution
Lead: Approved
1 candidate
N/A
1 buy · 0 sells (180d)
A transparent, data-derived signal for Lucid Diagnostics Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$194.6M
Cash
—
Quarterly Burn
$12.1M
Runway
—
Revenue
$1.3M
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| esoguard | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
100
Total value held
$39.6M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 8,309,540 | $9.6M |
| blackrock, inc. | 4,638,243 | $5.3M |
| masters capital management llc | 4,000,000 | $4.6M |
| two seas capital lp | 3,000,000 | $3.5M |
| geode capital management, llc | 2,245,350 | $2.6M |
| state street corp | 1,554,581 | $1.8M |
| wells fargo & company/mn | 1,274,390 | $1.5M |
| perkins capital management inc | 1,126,000 | $1.3M |
| sunbelt securities, inc. | 900,013 | $1.0M |
| northern trust corp | 670,585 | $771K |
Showing top 10 of 100 institutional holders of Lucid Diagnostics Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Lucid Diagnostics Inc.'s pipeline?
Lucid Diagnostics Inc. (LUCD) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Lucid Diagnostics Inc.'s lead drug candidate?
Lucid Diagnostics Inc.'s most advanced tracked candidate is esoguard (Approved) for Barrett's Esophagus (BE) and esophageal adenocarcinoma (EAC).
What is Lucid Diagnostics Inc.'s market capitalization?
Lucid Diagnostics Inc.'s market capitalization is approximately $194.6M.
Who is the CEO of Lucid Diagnostics Inc.?
Dr. Lishan Aklog M.D. is the chief executive officer of Lucid Diagnostics Inc. (LUCD).
Get the full picture on Lucid Diagnostics Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.